International comparison of median age at death from cystic fibrosis.

@article{Fogarty2000InternationalCO,
  title={International comparison of median age at death from cystic fibrosis.},
  author={Andrew W Fogarty and Richard B. Hubbard and John R. Britton},
  journal={Chest},
  year={2000},
  volume={117 6},
  pages={
          1656-60
        }
}
STUDY OBJECTIVES To compare international trends in mortality from cystic fibrosis. DESIGN Comparison of trends in median age at death using national mortality data. SETTING Data from 10 countries in North America, Europe, and Australasia. PARTICIPANTS All persons registered as having died of cystic fibrosis in specified years from 1980 to 1994. INTERVENTIONS Comparison of relative odds of death at the international median age at death for the year of death between countries for two… 

Figures, Tables, and Topics from this paper

Cystic fibrosis mortality trends in Spain among infants and young children: 1981–2004
TLDR
The results of this study show that, as in other Western countries, CF is no longer a major cause of death in childhood, and that the challenge now lies in caring for adults who suffer from this disease.
The application of current lifetable methods to compare cystic fibrosis median survival internationally is limited.
Improved survival among young patients with cystic fibrosis.
TLDR
Investigation of age-specific trends in survival among US patients with cystic fibrosis between 1985 and 1999 found female patients had poorer survival rates than male patients in the age range 2 to 20 years, and this gender gap did not narrow throughout time.
Rate of improvement of CF life expectancy exceeds that of general population—Observational death registration study☆☆☆
Cystic fibrosis mortality trends in France.
  • G. Bellis, M. Cazes, +5 authors G. Rault
  • Medicine
    Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
  • 2007
Survival Comparison of Patients With Cystic Fibrosis in Canada and the United States
TLDR
Whether using a standardized approach to data processing and survival calculations would confirm the observed difference between Canada and the United States and, if a survival gap persisted, to explore potential contributing factors is explored.
Effects of gender and age at diagnosis on disease progression in long-term survivors of cystic fibrosis.
TLDR
For patients with CF older than 40 years, the adult diagnosis correlates with delayed but equally severe pulmonary disease, and a gender-associated disadvantage remains for females diagnosed in childhood, but is not present for adult-diagnosed females.
Birth prevalence and survival in cystic fibrosis: a national cohort study in the Netherlands.
TLDR
The actual birth prevalence of CF in the Netherlands is clearly lower than it was 30 years ago and the difference in survival between the Netherlands and the United States, as observed in the cohorts born > 20 years ago, has disappeared.
Improved survival albeit with persistent disparities in prognosis for people with cystic fibrosis in European countries
TLDR
Data suggest that prognosis improvement in patients with CF is heavily dependent on the quality of the CF healthcare system, and survival is improving for people with cystic fibrosis in European countries albeit with persistent disparities in prognosis among countries.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 16 REFERENCES
Gender gap in cystic fibrosis mortality.
TLDR
In 1- to 20-year-old individuals with cystic fibrosis, survival in females was poorer than in males, and this "gender gap" was not explained by a wide variety of potential risk factors.
Effects of social class, sex, and region of residence on age at death from cystic fibrosis.
To determine the time trend in age at death from cystic fibrosis and the independent effects of social class, sex, and region of residence mortality data for England and Wales from 1959 to 1986 were
Incidence, population, and survival of cystic fibrosis in the UK, 1968–95
TLDR
The survival of successive cohorts continues to be better than earlier cohorts, the linear descent of the curves is still evident, and the infant mortality rate for cystic fibrosis is now under 20 per thousand per year and early childhood mortality is under five perousand per year.
Determinants of mortality from cystic fibrosis in Canada, 1970-1989.
TLDR
Proportional hazards analysis showed pulmonary function to be the best predictor of survival and poorer survival in females was associated with poorer weight, but the interrelation of declining pulmonary function, weight maintenance, sex, and mortality requires further study.
Incidence and mortality rates of cystic fibrosis in Japan, 1969-1992.
  • Y. Imaizumi
  • Medicine
    American journal of medical genetics
  • 1995
TLDR
The incidence rate and the death rate of cystic fibrosis (CF) in Japan were analyzed using Japanese Vital Statistics data for the period 1969-1992 and the mean age at death from CF was 3 years for both sexes, the value has been increased since 1979.
Absence of health insurance is associated with decreased life expectancy in patients with cystic fibrosis.
TLDR
The absence of health insurance was associated with increased mortality rate in children with CF and was a stronger predictor of mortality than variables previously shown to be associated with mortality for CF.
Hospital care for adults with cystic fibrosis: an overview and comparison between special cystic fibrosis clinics and general clinics using a patient questionnaire.
TLDR
Evidence is provided that adults with cystic fibrosis attending special cystic Fibrosis clinics receive more intensive care, have better symptom control, and are more satisfied with the service provided than those attending general clinics.
Severity of cystic fibrosis in patients homozygous and heterozygous for delta F508 mutation.
TLDR
There were no significant differences between the homozygous and heterozygous groups in the proportions with meconium ileus at birth, liver involvement, or chronic Pseudomonas aeruginosa infection, but significantly more of thehomozygous patients had onset of symptoms before the age of 6 months and had poorer lung function.
...
1
2
...